WhitTier Trust Company’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.2K | Buy |
128
+18
| +16% | +$9.45K | ﹤0.01% | 711 |
|
|
2025
Q1 | $69.8K | Sell |
110
-8
| -7% | -$5.07K | ﹤0.01% | 686 |
|
|
2024
Q4 | $84.1K | Sell |
118
-49
| -29% | -$34.9K | ﹤0.01% | 643 |
|
|
2024
Q3 | $176K | Sell |
167
-2
| -1% | -$2.1K | ﹤0.01% | 497 |
|
|
2024
Q2 | $178K | Buy |
169
+34
| +25% | +$35.7K | ﹤0.01% | 475 |
|
|
2024
Q1 | $130K | Sell |
135
-30
| -18% | -$28.9K | ﹤0.01% | 528 |
|
|
2023
Q4 | $145K | Hold |
165
| – | – | ﹤0.01% | 516 |
|
|
2023
Q3 | $136K | Hold |
165
| – | – | ﹤0.01% | 503 |
|
|
2023
Q2 | $119K | Hold |
165
| – | – | ﹤0.01% | 543 |
|
|
2023
Q1 | $136K | Sell |
165
-2
| -1% | -$1.64K | 0.01% | 507 |
|
|
2022
Q4 | $120K | Buy |
167
+55
| +49% | +$39.7K | ﹤0.01% | 526 |
|
|
2022
Q3 | $77K | Buy |
112
+57
| +104% | +$39.2K | ﹤0.01% | 604 |
|
|
2022
Q2 | $33K | Hold |
55
| – | – | ﹤0.01% | 740 |
|
|
2022
Q1 | $38K | Buy |
55
+25
| +83% | +$17.3K | ﹤0.01% | 721 |
|
|
2021
Q4 | $19K | Hold |
30
| – | – | ﹤0.01% | 819 |
|
|
2021
Q3 | $18K | Hold |
30
| – | – | ﹤0.01% | 855 |
|
|
2021
Q2 | $17K | Hold |
30
| – | – | ﹤0.01% | 814 |
|
|
2021
Q1 | $14K | Hold |
30
| – | – | ﹤0.01% | 820 |
|
|
2020
Q4 | $14K | Hold |
30
| – | – | ﹤0.01% | 798 |
|
|
2020
Q3 | $17K | Hold |
30
| – | – | ﹤0.01% | 757 |
|
|
2020
Q2 | $19K | Hold |
30
| – | – | ﹤0.01% | 725 |
|
|
2020
Q1 | $15K | Hold |
30
| – | – | ﹤0.01% | 738 |
|
|
2019
Q4 | $11K | Hold |
30
| – | – | ﹤0.01% | 829 |
|
|
2019
Q3 | $8K | Hold |
30
| – | – | ﹤0.01% | 854 |
|
|
2019
Q2 | $9K | Hold |
30
| – | – | ﹤0.01% | 842 |
|
|
2019
Q1 | $12K | Hold |
30
| – | – | ﹤0.01% | 805 |
|
|
2018
Q4 | $11K | Buy |
+30
| New | +$11K | ﹤0.01% | 823 |
|